Breast imaging and cancer diagnosis during the COVID-19 pandemic: recommendations from the Italian College of Breast Radiologists by SIRM
AbstractThe Italian College of Breast Radiologists by the Italian Society of Medical Radiology (SIRM) provides recommendations for breast care provision and procedural prioritization during COVID-19 pandemic, being aware that medical decisions must be currently taken balancing patient ’s individual and community safety: (1) patients having a scheduled or to-be-scheduled appointment for in-depth diagnostic breast imaging or needle biopsy should confirm the appointment or obtain a new one; (2) patients who have suspicious symptoms of breast cancer (in particular: new onset palpab le nodule; skin or nipple retraction; orange peel skin; unilateral secretion from the nipple) should request non-deferrable tests at radiology services; (3) asymptomatic women performing annual mammographic follow-up after breast cancer treatment should preferably schedule the appointment within 1 year and 3 months from the previous check, compatibly with the local organizational conditions; (4) asymptomatic women who have not responded to the invitation for screening mammography after the onset of the pandemic or have been informed of the suspension of the screening activity should schedule the check preferably within 3 months from the date of the not performed check, compatibly with local organizational conditions. The Italian College of Breast Radiologists by SIRM recommends precautions to protect both patients and healthcare workers (radiologists, radiographers, nurses, and re...
ConclusionsDespite the introduction of strict COVID-19 control measures, there was a high level of cancer outpatient satisfaction. The satisfaction levels may influence compliance, continuity of treatments, and patient –doctor communication, impacting the quality of clinical care in the next phases of the pandemic.
As solutions like remote care are becoming the norm, 3D-printing disrupts the normal supply chain and even the number of life science studies on tools like artificial intelligence (A.I.) skyrocket, it’s become clear that we are not anticipating the digital health era; we are in the digital health era due to the COVID-19 pandemic. First and foremost, it’s an era defined by a cultural transformation that will upend the traditional structure of healthcare. Clinical-grade sensors are available outside of the ivory towers of medicine; patients demand such tools so that they can become more proactive in mana...
We report on patterns of prescription in our centre and how it has changed due to COVID-19.
During the COVID-19 pandemic, women have reportedly skipped or delayed their regular breast cancer screenings. This may lead to a surge in breast cancer diagnoses in the months ahead. That's according to a study in JAMA. October is Breast Cancer Awareness Month and Dr. Katie Hunt, a Mayo Clinic radiologist, says it's the perfect time to [...]
Background: The new respiratory illness commonly referred to as “corona virus” and officially called COVID-19 has changed life and delivery of health care worldwide. In UK it has resulted in major changes as not only halted the breast screening but also forced the breast unit to undergo reconfiguration for safety of patients and staff. The risk of becoming s eriously ill from COVID-19 is low for most people. However, it’s very important to know that people being treated for breast cancer may have a higher risk of severe illness if they get COVID-19.
Background: The COVID-19 pandemic, and the resulting measures, are impacting daily life and medical management of patients with breast cancer. We evaluated to what extent these changes have affected quality of life, and physical and psychosocial wellbeing of patients (being) treated for breast cancer.
Background: The recent COVID-19 pandemic has caused profound changes on the health-care systems as well as deleterious repercussions on the care of patients with cancer. In this comparative study, we sought to evaluate the effects the COVID-19 pandemic on the surgical management of breast cancer in a Breast Unit belonging to an Italian region with a low incidence of COVID-19 infection.
This study aimed to estimate the effects of four restart strategies after the disruption on screening capacity and cancer burden.
(European Organisation for Research and Treatment of Cancer) During the COVID-19 pandemic, many countries paused their breast cancer screening programmes. A new study, presented at the 12th European Breast Cancer Conference, suggests that the disruption to screening could result in an increase in the proportion of women who die of breast cancer.